Retail investors started today, Dec. 23, subscription to 2.66 million shares of Almoosa Health Co.,at SAR 127 each, as set by the book-building process.
The retail offering represents 20% of the total offer.
The subscription process for the retail tranche will run for two days until Dec. 24.
The Capital Market Authority (CMA) approved, in September 2024, the company’s request to float 13.29 million shares, or 30% of the capital, in an initial public offering (IPO) on the Main Market (TASI). The offering represents 37.97% of its pre-IPO capital, with a nominal value per share of SAR 10.
Retail investors started today, Dec. 23, subscription to 2.66 million shares of Almoosa Health Co.,at SAR 127 each, as set by the book-building process.
The retail offering represents 20% of the total offer.
The subscription process for the retail tranche will run for two days until Dec. 24.
The Capital Market Authority (CMA) approved, in September 2024, the company’s request to float 13.29 million shares, or 30% of the capital, in an initial public offering (IPO) on the Main Market (TASI). The offering represents 37.97% of its pre-IPO capital, with a nominal value per share of SAR 10.
